A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 186,400 shares of LNTH stock, worth $20.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
186,400
Previous 389,500 52.14%
Holding current value
$20.5 Million
Previous $24.2 Million 38.26%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$58.87 - $83.05 $1.6 Million - $2.26 Million
-27,212 Reduced 8.24%
302,974 $24.3 Million
Q1 2024

May 15, 2024

SELL
$51.07 - $68.26 $28 Million - $37.4 Million
-548,368 Reduced 62.42%
330,186 $20.6 Million
Q4 2023

Feb 14, 2024

BUY
$55.6 - $77.89 $40 Million - $56.1 Million
720,253 Added 454.99%
878,554 $54.5 Million
Q3 2023

Nov 14, 2023

SELL
$60.27 - $90.75 $4.9 Million - $7.38 Million
-81,297 Reduced 33.93%
158,301 $11 Million
Q2 2023

Aug 14, 2023

SELL
$82.41 - $99.65 $7.36 Million - $8.9 Million
-89,337 Reduced 27.16%
239,598 $20.1 Million
Q1 2023

May 15, 2023

SELL
$47.76 - $82.86 $21.1 Million - $36.6 Million
-441,543 Reduced 57.31%
328,935 $27.2 Million
Q4 2022

Feb 14, 2023

BUY
$48.76 - $77.67 $37.6 Million - $59.8 Million
770,478 New
770,478 $39.3 Million
Q2 2022

Aug 15, 2022

SELL
$55.54 - $72.65 $20.2 Million - $26.4 Million
-363,232 Reduced 30.09%
843,747 $55.7 Million
Q1 2022

May 16, 2022

BUY
$24.28 - $56.64 $24.5 Million - $57.1 Million
1,008,390 Added 507.78%
1,206,979 $66.8 Million
Q4 2021

Feb 14, 2022

BUY
$22.54 - $30.44 $2.04 Million - $2.76 Million
90,639 Added 83.96%
198,589 $5.74 Million
Q3 2021

Nov 15, 2021

BUY
$24.23 - $28.59 $2.1 Million - $2.48 Million
86,861 Added 411.88%
107,950 $2.77 Million
Q2 2021

Aug 16, 2021

BUY
$19.51 - $27.64 $133,780 - $189,527
6,857 Added 48.18%
21,089 $582,000
Q1 2021

May 17, 2021

SELL
$13.77 - $21.66 $650,907 - $1.02 Million
-47,270 Reduced 76.86%
14,232 $304,000
Q4 2020

Feb 16, 2021

SELL
$10.75 - $14.91 $472,312 - $655,085
-43,936 Reduced 41.67%
61,502 $830,000
Q3 2020

Nov 16, 2020

SELL
$11.98 - $16.34 $264,578 - $360,868
-22,085 Reduced 17.32%
105,438 $1.34 Million
Q2 2020

Aug 14, 2020

SELL
$10.34 - $15.51 $849,038 - $1.27 Million
-82,112 Reduced 39.17%
127,523 $1.82 Million
Q1 2020

May 15, 2020

BUY
$9.11 - $20.05 $1.07 Million - $2.36 Million
117,735 Added 128.11%
209,635 $2.68 Million
Q4 2019

Feb 14, 2020

BUY
$18.47 - $24.03 $1.52 Million - $1.98 Million
82,447 Added 872.18%
91,900 $1.89 Million
Q3 2019

Nov 14, 2019

SELL
$21.01 - $28.94 $101,730 - $140,127
-4,842 Reduced 33.87%
9,453 $236,000
Q2 2019

Aug 14, 2019

SELL
$23.33 - $28.3 $279,703 - $339,288
-11,989 Reduced 45.61%
14,295 $404,000
Q1 2019

May 15, 2019

SELL
$14.93 - $25.1 $377,669 - $634,929
-25,296 Reduced 49.04%
26,284 $0
Q4 2018

Feb 14, 2019

BUY
$12.68 - $19.01 $392,686 - $588,720
30,969 Added 150.25%
51,580 $807,000
Q3 2018

Nov 13, 2018

SELL
$13.1 - $16.35 $251,231 - $313,560
-19,178 Reduced 48.2%
20,611 $0
Q2 2018

Aug 10, 2018

SELL
$13.65 - $18.7 $579,920 - $794,469
-42,485 Reduced 51.64%
39,789 $0
Q1 2018

May 11, 2018

BUY
$14.85 - $24.3 $1.22 Million - $2 Million
82,274 New
82,274 $1.31 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $7.56B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.